Breakthrough treatments, such as mRNA and personalized therapies, have created tremendous opportunities for pharmaceutical companies but require intricate manufacturing, supply chain and quality control processes that are difficult to support. In addition, these complex products are coming to market faster than ever, leaving less time to develop and optimize the manufacturing process.

AWS and Accenture are collaborating at several pharmaceutical companies to transform these processes. In this session, we will identify key learnings and patterns such as how data is being used to optimize clinical trials, accelerate products to market and expand their pipelines to become more patient-centric.